In depth view into DVAX (Dynavax Technologies) stock including the latest price, news, dividend history, earnings information and financials. DVAX | Complete Dynavax Technologies Corp. stock news by MarketWatch. Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s Shares of Dynavax (NASDAQ:DVAX) were skyrocketing 30.2% higher as of 3:47 p.m. EDT on Monday. DOWNLOAD DATA Data is currently not available ... Get up to 10 years of daily historical stock prices & volumes. Dynavax Technologies Corporation (NASDAQ:DVAX) went up by 3.25% from its latest closing price compared to the recent 1-year high of $12.44. The score provides a forward-looking, one-year measure of credit Dynavax Technologies (NASDAQ: DVAX) is $9.6 last updated Mon Feb 22 2021 21:00:02 GMT+0000 (Coordinated Universal Time). Dynavax Technologies Corporation (Nasdaq: DVAX) today reported that in connection with the commencement of Ms. MacDonald's employment with the Company as Senior Vice President and Chief Financial Officer on March 1, 2021, the Company granted her a non-statutory stock option to purchase 350,000 shares of Dynavax common stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. DVAX - Dynavax Technologies Corp Stock quote - CNNMoney.com Markets DVAX Stock Message Board for Investors. What happened. Currency in USD, Trade prices are not sourced from all markets. The big gain came after the company announced better-than-expected fourth-quarter results after the market close on Thursday. Emeryville, California 94608 . TradingView India. Company Profile. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. All rights reserved. Find the latest Dynavax Technologies Corporatio (DVAX) stock quote, history, news and other vital information to help you with your stock trading and investing. Scaling The Peaks The stock price is undervalued: For a substantial part of 2020, Dynavax was one of the best stocks under $5 to buy in biotech, with a 52-week low of $1.80. This is why it happened. The company’s stock price has collected 14.46% of gains in the last five trading sessions. Data provided by Edgar Online. Federated Global Investment Management Corp. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy. The stock options were granted on February 1, 2021 at an exercise price of $10.27 per share, which is equal to the closing price of Dynavax (DVAX) common stock on the date of grant. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. 6:04a Baidu stock price target raised to $450 from $180 at Susquehanna ... DVAX Profile. (Biotech Stocks Hitting 52-week Highs Feb. 25). Gainers * Average Estimates in Million (e.g. balance sheet and inputs from the stock market. Yet the stock price sits at $8.50. The big gain came after the company announced better-than-expected fourth-quarter results after the market close on Thursday. View the real-time DVAX price chart on Robinhood and decide if you want to buy or sell commission-free. Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares climbed 48% to close at $5.58 on Friday. Here's a roundup of top developments in the biotech space over the last 24 hours: Plus500. Dividend). Dynavax Technologies Corp. 2100 Powell Street. Dynavax Technologies Corp. Stock Price, News and Company Updates. Stock analysis for Dynavax Technologies Corp (DVAX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Subscribe to Premium to view Fair Value for DVAX. Dynavax Technologies Corp live price charts and stock performance over time. Why Dynavax Stock Is Crushing It Today. © 2021 Insider Inc. and finanzen.net GmbH (Imprint). DVAX updated stock price target summary. © 2021 Verizon Media. Source: FactSet. Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares jumped 52.8% to $5.76. The upside potential (average analyst target price relative to current price) of DVAX is higher than 86.4% of all US stocks. Get the latest stock price for Dynavax Technologies Corporation (DVAX:US), plus the latest news, recent trades, charting, insider activity, and analyst ratings. Lixte Biotech recently said it will present its anti-cancer therapy enhancer at HC Wainwright Global Life Sciences Conference being held March 9-10, 2021. Check out our DVAX stock analysis, current DVAX quote, charts, and historical prices for Dynavax Technologies stock DVAX: Get the latest Dynavax Technologies stock price and detailed information including DVAX news, historical charts and realtime prices. risk, allowing investors to make better decisions and streamline their work ow. Find market predictions, DVAX financials and market news. 76.4% of retail CFD accounts lose money, Registration on or use of this site constitutes acceptance of our, Dynavax surges on prospects for COVID–19 vaccine adjuvant, 48 Stocks Moving In Friday's Mid-Day Session, Xtant Medical, Sensus Healthcare leads healthcare gainers; Tricida, Recro Pharma among major losers, The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida. The stock price of Dynavax Technologies Corporation (NASDAQ: DVAX) – a biopharmaceutical company focused on developing and commercializing novel vaccines – increased by over 9% pre-market as of 8:13 AM ET. Disclaimer | DVAX Stock Analysis Overview What this means: Dynavax Technologies (DVAX) gets an Overall Rank of 73, which is an above average rank under InvestorsObserver's stock ranking system. A high-level overview of Dynavax Technologies Corporation (DVAX) stock. Q When is the next Dynavax Technologies (DVAX) dividend? The stock price of Dynavax Technologies Corporation (NASDAQ: DVAX) increased by 62.76% today. Stock quotes by finanzen.net. Stock quote and company snapshot for DYNAVAX TECHNOLOGIES CORP (DVAX), including profile, stock chart, recent news and events, analyst opinions, and research reports. Lixte Biotech recently said it will present its anti-cancer therapy enhancer at HC Wainwright Global Life Sciences Conference being held March 9-10, 2021. The stock price of Dynavax Technologies Corporation (NASDAQ: DVAX) — a biopharmaceutical company focused on developing and commercializing vaccines — increased by 62.76% today as it went from a previous close of $6.31 to $10.27. Made In NYC | In addition, it also granted nonstatutory stock options to purchase an aggregate of 74,300 shares of Dynavax common stock as inducements to four newly-hired employees in connection with commencement of their employment with the Company. Suite 900. The stock price of Dynavax Technologies Corporation (NASDAQ: DVAX) increased by over 9% pre-market. DVAX Stock Summary. Dynavax Technologies Corporation Common Stock (DVAX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Shares of Dynavax Technologies (NASDAQ: DVAX) were soaring 18.8% as of 10:50 a.m. EST on Friday. Gainers View live DYNAVAX TECHNOLOGIES CORP chart to track its stock's price action. Shareholder percentage totals can add to more than 100% because some holders are included in the free float. View live DYNAVAX TECHNOLOGIES CORP chart to track its stock's price action. Dow Jones, a News Corp company About WSJ. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Dynavax against related stocks people have also bought. Dynavax Technologies Corp's number of analysts covering the stock is greater than 27.74% of all US stocks. Dynavax expects to make between $40 million and $60 million in the first quarter of this year from its CpG 1018 vaccine adjuvant. DVAX Historical Data 1M 6M YTD 1Y 5Y MAX. Revenue) or per share (e.g. Shares of Dynavax Technologies (NASDAQ: DVAX) were soaring 18.8% as of 10:50 a.m. EST on Friday. This is why it happened. Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Ryan Spencer, Chief Executive Officer, will present at the H.C. Wainwright Virtual 2021 Global Life Sciences Conference being held March 9-10, 2021. Dynavax stock forecast & analyst price target predictions based on 4 analysts offering 12-months price targets for DVAX in the last 3 months. Message Board Total Posts: 63 Get Dynavax Technologies Corp (DVAX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Find real-time DVAX - Dynavax Technologies Corp stock quotes, company profile, news and forecasts from CNN Business. DVAX has a greater average analyst price target than 34.22% of all US stocks. The biotech didn't report any new developments today. View the latest Dynavax Technologies Corp. (DVAX) stock price, news, historical charts, analyst ratings and financial information from WSJ. account day-to-day movements in market value compared to a company’s liability structure. Use technical analysis tools such as candles & Fibonacci to generate different instrument comparisons. DVAX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 82.5% of US stocks. Updated daily, it takes into Find market predictions, DVAX financials and market news. About Dynavax Dynavax is a commercial stage biopharmaceutical company developing and … Dynavax is a huge buy from every historical perspective. Press Release reported on 03/01/21 that Dynavax to Present at the H.C. Wainwright Virtual 2021 Global Life Sciences Conference The stock price for . View real-time stock prices and stock quotes for a full financial overview. Real time Dynavax Technologies (DVAX) stock price quote, stock graph, news & analysis. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. All rights reserved. The CEO has said the First Quarter will produce more revenue than what the company has produced since 2004 . DVAX's price/sales ratio is 20.68; that's higher than the P/S ratio of 90.92% of US stocks. Commerce Policy |